These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29207143)

  • 21. A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment.
    Farajpour Z; Rahbarizadeh F; Kazemi B; Ahmadvand D
    Biochem Biophys Res Commun; 2014 Mar; 446(1):132-6. PubMed ID: 24569074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a novel anti-EGFR nanobody by phage display and its distinct paratope and epitope via homology modeling and molecular docking.
    Xi X; Sun W; Su H; Zhang X; Sun F
    Mol Immunol; 2020 Dec; 128():165-174. PubMed ID: 33130376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligoclonal selection of nanobodies targeting vascular endothelial growth factor.
    Ahadi M; Ghasemian H; Behdani M; Kazemi-Lomedasht F
    J Immunotoxicol; 2019 Dec; 16(1):34-42. PubMed ID: 30409071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent CD4+ T cell-associated antitumor memory responses induced by trifunctional bispecific antibodies in combination with immune checkpoint inhibition.
    Deppisch N; Ruf P; Eißler N; Lindhofer H; Mocikat R
    Oncotarget; 2017 Jan; 8(3):4520-4529. PubMed ID: 27966460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Streamlined method for parallel identification of single domain antibodies to membrane receptors on whole cells.
    Rossotti M; Tabares S; Alfaya L; Leizagoyen C; Moron G; González-Sapienza G
    Biochim Biophys Acta; 2015 Jul; 1850(7):1397-404. PubMed ID: 25819371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
    Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
    Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of a synthetic phage-displayed Nanobody library with CDR3 regions randomized by trinucleotide cassettes for diagnostic applications.
    Yan J; Li G; Hu Y; Ou W; Wan Y
    J Transl Med; 2014 Dec; 12():343. PubMed ID: 25496223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TIRC7 inhibits Th1 cells by upregulating the expression of CTLA‑4 and STAT3 in mice with acute graft‑versus‑host disease.
    Zhu F; Qiu T; Zhu S; Zhao K; Chen C; Qiao J; Pan B; Yan Z; Chen W; Liu Q; Wu Q; Cao J; Sang W; Zeng L; Sun H; Li Z; Xu K
    Oncol Rep; 2020 Jul; 44(1):43-54. PubMed ID: 32319655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bactrian camel nanobody-based immunoassay for specific and sensitive detection of Cry1Fa toxin.
    Wang P; Li G; Yan J; Hu Y; Zhang C; Liu X; Wan Y
    Toxicon; 2014 Dec; 92():186-92. PubMed ID: 25448390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4.
    Horspool JH; Perrin PJ; Woodcock JB; Cox JH; King CL; June CH; Harlan DM; St Louis DC; Lee KP
    J Immunol; 1998 Mar; 160(6):2706-14. PubMed ID: 9510170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ctla-4 blockade plus adoptive T-cell transfer promotes optimal melanoma immunity in mice.
    Mahvi DA; Meyers JV; Tatar AJ; Contreras A; Suresh M; Leverson GE; Sen S; Cho CS
    J Immunother; 2015; 38(2):54-61. PubMed ID: 25658614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
    Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
    Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity.
    Cao K; Wang G; Li W; Zhang L; Wang R; Huang Y; Du L; Jiang J; Wu C; He X; Roberts AI; Li F; Rabson AB; Wang Y; Shi Y
    Oncogene; 2015 Dec; 34(49):5960-70. PubMed ID: 25745993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A camel anti-lysozyme CDR3 only domain antibody selected from phage display VHH library acts as potent lysozyme inhibitor.
    Qiu L; Feng Y; Ma X; Li J
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):513-519. PubMed ID: 28475681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review).
    Yu S; Xiong G; Zhao S; Tang Y; Tang H; Wang K; Liu H; Lan K; Bi X; Duan S
    Int J Mol Med; 2021 Feb; 47(2):444-454. PubMed ID: 33416134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
    Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
    J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective treatment of preexisting melanoma with whole cell vaccines expressing alpha(1,3)-galactosyl epitopes.
    Rossi GR; Mautino MR; Unfer RC; Seregina TM; Vahanian N; Link CJ
    Cancer Res; 2005 Nov; 65(22):10555-61. PubMed ID: 16288048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
    Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
    J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.